Gameto Newsroom

Stay up to date with the latest news from Gameto

 
Press Releases
April 24, 2025

Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo Study

Read More
Press Releases
April 7, 2025

Gameto Announces Landmark Pregnancy Rate for iPSC-Derived Fertilo, Achieving More Than Double the Success Rate of Standard IVM

Read More
Press Releases
January 30, 2025

Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials

Read More
Press Releases
April 9, 2024

Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments

Read More
Press Releases
April 2, 2024

Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation

Read More
Press Releases
October 4, 2023

REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs

Read More
Press Releases
June 21, 2023

Gameto Named as 2023 Technology Pioneer by World Economic Forum

Read More
Press Releases
April 28, 2023

Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer

Read More